News
Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...
Alcon shares fell after the Swiss eye-care giant trimmed its full-year guidance due to President Trump’s trade tariffs.
Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...
Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that ...
For almost four decades, Tom McDonald was a part of the team at Fort Worth-born Alcon, which continues to make innovative moves in the world of eyecare products. He recaps the company’s first five ...
Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.
Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on ...
Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the ...
Global eye care leader Alcon has announced it will acquire Lake Forest-based Staar Surgical, a manufacturer of implantable ...
Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...
Shares of Alcon fell after the company posted a lower second-quarter profit and cut its full-year sales outlook, saying it expected a full-year tariff impact of $100 million. The stock was down 9.1% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results